REDHILL BIOPHARMA LTD.

Analyst Reco. RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Market Closed - Nasdaq Other stock markets 21:30:00 30/04/2024 BST			5-day change	1st Jan Change
0.4313 ^USD	-0.39%		+0.82%	-70.46%

04-24	RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study	CI
04-08	RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Redhill Biopharma Says Opaganib Cuts Mortality Rates by 70.2% in Severe COVID-19 Patients	07/02/22	MT
Ascendiant Capital Adjusts Price Target on Redhill Biopharma to $19 From $26, Maintains Buy Rating	27/12/21	MT
Ladenburg Thalmann Adjusts Redhill Biopharma's Price Target to $9 from $21, Maintains Buy Rating	01/12/21	MT
REDHILL BIOPHARMA : HC Wainwright Trims Redhill Biopharma's Price Target to $21 From $23, Keeps Buy Rating	15/09/21	MT
Redhill Biopharma : Shares Climb after Cantor Fitzgerald Initiates Coverage With Overweight Rating	31/08/21	MT
Today on Wall Street: US tech giants return to top spot	31/08/21
ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron...	31/08/21
REDHILL BIOPHARMA : Cantor Fitzgerald Starts Redhill Biopharma at Overweight With $22 Price Target	31/08/21	MT
REDHILL BIOPHARMA : WBB Securities Downgrades Redhill Biopharma to Buy Rating From Strong Buy	28/05/21	MT
REDHILL BIOPHARMA : HC Wainwright Starts Redhill Biopharma at Buy With $23 Price Target	18/05/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer